Remove Avalon Remove Funding Remove Pricing
article thumbnail

AnaptysBio Sets Estimated IPO Pricing Range

socalTECH

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB.

article thumbnail

AnaptysBio Up Slightly In IPO

socalTECH

Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M

article thumbnail

Interview with Derrick Oien, Intercasting

socalTECH

in funding from Venrock, Avalon, and Masthead. And it also looks like there's some pricing difference between carriers--is this something you drive, or do they set pricing? Intercasting is backed by $17.5M What exactly are your mobile social networking applications? Derrick Oien: That's driven by the operator. a month.